Funder: National Institutes of Health

Due Dates: May 28, 2025 | September 29, 2025 | January 28, 2026 | May 28, 2026 | September 28, 2026 | January 28, 2027

Funding Amounts: No budget cap; project period up to 5 years (R61 ≤2 years, R33 ≤4 years); budgets must reflect actual project needs.

Summary: Supports translational and small clinical studies to advance therapeutic and diagnostic neural devices for nervous or neuromuscular system disorders.

Key Information: Milestone-driven, two-phase (R61/R33) mechanism; required attachments include Gantt chart, IP strategy, needs assessment, long-term care, and team management plan.